{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:55:09Z","timestamp":1790016909228,"version":"4.0.1"},"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009516","name":"Universit\u00e9 Sorbonne Paris Cit\u00e9","doi-asserted-by":"publisher","award":["PhD grant"],"award-info":[{"award-number":["PhD grant"]}],"id":[{"id":"10.13039\/501100009516","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211695","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T18:30:43Z","timestamp":1550169043000},"page":"e0211695","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-2200","authenticated-orcid":true,"given":"Lorene","family":"Zerah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9-Sosata","family":"Bun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Guillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bonnet-Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"9990","key":"ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","volume":"386","author":"JL Mega","year":"2015","journal-title":"Lancet"},{"issue":"20","key":"ref2","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2016.16201","article-title":"US Emergency department visits for outpatient adverse drug events, 2013\u20132014","volume":"316","author":"N Shehab","year":"2016","journal-title":"JAMA"},{"issue":"16","key":"ref3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"ML Hansen","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2007.03064.x","article-title":"Incidence of fatal adverse drug reactions: a population based study","volume":"65","author":"K Wester","year":"2008","journal-title":"Brit J Clin Pharmaco"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","article-title":"National trends in ambulatory oral anticoagulant use","volume":"128","author":"GD Barnes","year":"2015","journal-title":"Am J Med"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00228-016-2170-6","article-title":"Hospitalizations due to preventable adverse reactions\u2014a systematic review","volume":"73","author":"NS Patel","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s11096-016-0335-0","article-title":"Assessing prescribing of NSAIDs, antiplatelets, and anticoagulants in Canadian family medicine using chart review","volume":"38","author":"K Hamilton","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"e1002530","DOI":"10.1371\/journal.pmed.1002530","article-title":"The importance and challenges of shared decision making in older people with multimorbidty","volume":"15","author":"T Hoffmann","year":"2018","journal-title":"PLoS Med"},{"issue":"21","key":"ref9","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2010.04.063","article-title":"Antithrombotic therapy in the elderly","volume":"56","author":"D Capodanno","year":"2010","journal-title":"J am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"L Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease","volume":"152","author":"GN Levine","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref12","unstructured":"Goblirsch G, Bershow S, Cummings K, Hayes R, Kokoszka M, Lu Y, et al. Stable coronary artery disease. Institute for Clinical Systems Improvement (ICSI). 2013. http:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.658.3632&rep=rep1&type=pdf<\/ext-link>"},{"issue":"38\u00c0","key":"ref13","first-page":"2949","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"G Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"ref14","article-title":"Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease","year":"2013","journal-title":"NICE Guideline"},{"key":"ref15","article-title":"MI\u2014secondary prevention: secondary prevention in primary and secondary care for patients following a myocardial infarction: partial update of NICE CG48","year":"2013","journal-title":"NICE Guideline"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cjca.2014.05.013","article-title":"Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease","volume":"30","author":"G Mancini","year":"2014","journal-title":"Can J Cardiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1253\/circj.CJ-66-0053","article-title":"Guidelines for secondary prevention of myocardial infarction (JCS 2011)","volume":"77","year":"2013","journal-title":"Circ J"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"M Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"1357","key":"ref19","first-page":"122","article-title":"New Zealand 2012 guidelines for the management of non ST- elevation acute coronary syndromes","volume":"125","year":"2012","journal-title":"N Z Med J"},{"issue":"3","key":"ref20","first-page":"214","article-title":"Guidelines on unstable angina and non-ST-elevation myocardial infarction","volume":"105","author":"GS Feitosa-Filho","year":"2015","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/HPC.0b013e31825ac653","article-title":"2012 Oman Heart Association simplified guidelines for the management of patients with unstable angina\/non\u2013St-elevation myocardial infarction","volume":"11","author":"MH El-Deeb","year":"2012","journal-title":"Crit Pathw Cardiol"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"B Ibanez","year":"2017","journal-title":"Eur Heart J"},{"key":"ref23","article-title":"Management of acute ST segment elevation myocardial infarction (STEMI) 2014\u2014(3RD Edition)","year":"2014","journal-title":"Clinical Practice Guidelines"},{"key":"ref24","first-page":"127","article-title":"ST-elevation myocardial infarction: New Zealand Management Guidelines, 2013","volume":"126","year":"2013","journal-title":"N Z Med J"},{"key":"ref25","article-title":"Stable coronary artery disease 2018","year":"2018","journal-title":"Clinical Practice Guidelines"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cjca.2018.08.026","article-title":"2018 focused update of the Canadian cardiovascular society guidelines for the management of atrial fibrillation","volume":"34","author":"JG Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"GYH Lip","year":"2018","journal-title":"Chest"},{"issue":"38","key":"ref28","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jfma.2016.10.005","article-title":"2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation","volume":"115","author":"C-E Chiang","year":"2016","journal-title":"J Formos Med Assoc"},{"issue":"13","key":"ref30","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS Guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"RL Page","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref31","article-title":"Atrial Fibrillation\u2013Diagnosis and Management","year":"2015","journal-title":"BCGuidelinesca"},{"key":"ref32","article-title":"New oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation","year":"2012","journal-title":"Canadian agency for Drugs and Technologies in Health"},{"key":"ref33","article-title":"Atrial fibrillation: management","year":"2014","journal-title":"NICE Guideline"},{"issue":"21","key":"ref34","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"64","author":"CT January","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/HPC.0000000000000015","article-title":"2014 Oman Heart Association protocol for the management of acute atrial fibrillation","volume":"13","author":"MH El-Deeb","year":"2014","journal-title":"Crit Pathw Cardiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1253\/circj.CJ-66-0092","article-title":"Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013)","volume":"78","year":"2014","journal-title":"Circ J"},{"key":"ref37","article-title":"Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation","year":"2015","journal-title":"BCGuidelinesca"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4070\/kcj.2018.0339","article-title":"2018 Korean guideline of atrial fibrillation management","volume":"48","author":"B Joung","year":"2018","journal-title":"Korean Circ J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"27","author":"D Brieger","year":"2018","journal-title":"Heart Lung Circ"},{"key":"ref40","article-title":"Updated clinical practice guideline: pharmacologic management of newly detected atrial fibrillation","volume":"19","year":"2017","journal-title":"Leawood KS American Academy of Family Physicians"},{"key":"ref41","article-title":"National evidence-based guideline on secondary prevention of cardiovascular disease in type 2 diabetes","year":"2015","journal-title":"National evidence-based guideline on secondary prevention of cardiovascular disease in type 2 diabetes"},{"issue":"39","key":"ref42","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"34","author":"L Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"PO Vandvik","year":"2012","journal-title":"Chest"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.2337\/dc15-S011","article-title":"Cardiovascular Disease and Risk Management","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"39","author":"V Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejvs.2017.06.021","article-title":"Management of atherosclerotic carotid and vertebral artery disease: 2017, clinical practice guidelines of the European Society for Vascular Surgery (ESVS)","volume":"55","author":"AR Naylor","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1002\/ccd.22983","article-title":"2011 ASA\/ACCF\/AHA\/AANN\/AANS\/ACR\/ASNR\/CNS\/SAIP\/SCAI\/SIR\/SNIS\/SVM\/SVS Guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary","volume":"81","author":"TG Brott","year":"2013","journal-title":"Cathet Cardiovasc Intervent"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"e669S","DOI":"10.1378\/chest.11-2307","article-title":"Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"P Alonso-Coello","year":"2012","journal-title":"Chest"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","article-title":"Joint British Societies\u2019 consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","author":"JBS Board","year":"2014","journal-title":"Heart"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"69","author":"MD Gerhard-Herman","year":"2017","journal-title":"J am Coll Cardiol"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1024\/0301-1526\/a000603","article-title":"German guideline on the diagnosis and treatment of peripheral artery disease\u2014a comprehensive update 2016","volume":"46","author":"H Lawall","year":"2017","journal-title":"Vasa"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"MS Conte","year":"2015","journal-title":"J Vasc Surg"},{"issue":"3","key":"ref53","first-page":"168","article-title":"Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type","volume":"29","author":"B Fuentes","year":"2014","journal-title":"Neurologia"},{"key":"ref54","unstructured":"Intercollegiate Stroke Working Party. National clinical guideline for stroke. Royal College of physicians. 2016. https:\/\/www.strokeaudit.org\/SupportFiles\/Documents\/Guidelines\/2016-National-Clinical-Guideline-for-Stroke-5t-(1).aspx<\/ext-link>"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1747493017694391","article-title":"2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack","volume":"12","author":"Y Wang","year":"2017","journal-title":"Int J Stroke"},{"key":"ref56","article-title":"Stroke and Transient Ischemic Attack\u2014Acute and Long-Term Management","year":"2015","journal-title":"BCGuidelinesca"},{"key":"ref57","article-title":"Management of ischaemic stroke","year":"2012","journal-title":"Clinical Practice Guidelines"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"e601S","DOI":"10.1378\/chest.11-2302","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"MG Lansberg","year":"2012","journal-title":"Chest"},{"issue":"10","key":"ref59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ene.13381","article-title":"European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis\u2014endorsed by the European Academy of Neurology","volume":"24","author":"JM Ferro","year":"2017","journal-title":"Eur J Neurol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/1747493018786616","article-title":"Canadian Stroke Best Practice Recommendations for acute stroke management: prehospital, emergency department, and acute inpatient stroke care, 6th edition, update 2018","volume":"13","author":"JM Boulanger","year":"2018","journal-title":"Int J Stroke"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"WJ Powers","year":"2018","journal-title":"Stroke"},{"key":"ref62","first-page":"1","article-title":"The diagnosis and management of stroke and transient ischaemic attack","year":"2016","journal-title":"Transforming Healthcare"},{"issue":"36","key":"ref63","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"H Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"ref64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease","volume":"70","author":"RA Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"RP Whitlock","year":"2012","journal-title":"Chest"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.2012.09249.x","article-title":"Guidelines on the investigation and management of venous thrombosis at unusual sites","volume":"159","author":"C Tait","year":"2012","journal-title":"Br J Haematol"},{"key":"ref67","article-title":"Prevention and treatment of venous thromboembolism","year":"2013","journal-title":"Clinical Practice Guidelines"},{"key":"ref68","article-title":"Venous thromboembolism diagnosis and treatment","year":"2012","journal-title":"Institute for Clinical Systems Improvement"},{"key":"ref69","article-title":"Pulmonary embolism","year":"2015","journal-title":"NICE Guideline"},{"issue":"17","key":"ref70","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1503\/cmaj.141614","article-title":"Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline","volume":"187","author":"D Liu","year":"2015","journal-title":"CMAJ"},{"issue":"4 Pt2","key":"ref71","first-page":"261","article-title":"Venous thromboembolism: prophylactic and therapeutic practice guideline","volume":"103","author":"BF Jacobson","year":"2013","journal-title":"S Afr Med J"},{"issue":"43","key":"ref72","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"SV Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"ref73","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1538-7836.2012.04662.x","article-title":"Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH","volume":"10","author":"T Baglin","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"3","key":"ref74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5758\/vsi.2016.32.3.77","article-title":"Diagnosis and treatment of lower extremity deep vein thrombosis: Korean Practice Guidelines","volume":"32","author":"S-K Min","year":"2016","journal-title":"Vasc Specialist Int"},{"key":"ref75","article-title":"Antiplatelet treatment","year":"2015","journal-title":"NICE Guideline"},{"key":"ref76","article-title":"Antithrombotics: indications and management. A national clinical guideline","year":"2013","journal-title":"Scottish Intercollegiate Guidelines Network (SIGN)"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cjca.2017.12.012","article-title":"2018 Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy","volume":"34","author":"SR Mehta","year":"2018","journal-title":"Can J Cardiol"},{"key":"ref78","article-title":"Anticoagulation\u2014oral","year":"2016","journal-title":"NICE Guideline"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic Therapy for VTE Disease","volume":"149","author":"C Kearon","year":"2016","journal-title":"Chest"},{"issue":"3","key":"ref80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"39","author":"M Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","article-title":"ACC\/AHA Versus ESC Guidelines on dual antiplatelet therapy","volume":"72","author":"D Capodanno","year":"2018","journal-title":"J am Coll Cardiol"},{"issue":"2","key":"ref82","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach","volume":"137","author":"GYH Lip","year":"2010","journal-title":"Chest"},{"issue":"5","key":"ref83","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"R Pisters","year":"2010","journal-title":"Chest"},{"issue":"1","key":"ref84","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12875-016-0546-4","article-title":"The burden of cardiovascular morbidity in a European Mediterranean population with multimorbidity: a cross-sectional study","volume":"17","author":"C Viol\u00e1n","year":"2016","journal-title":"BMC Fam Pract"},{"issue":"1","key":"ref85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jclinepi.2013.07.012","article-title":"Median life span of a cohort of national institute for health and care excellence clinical guidelines was about 60 months","volume":"67","author":"LJH Alderson","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"ref86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-147-4-200708210-00179","article-title":"How quickly do systematic reviews go out of date? A survival analysis","volume":"147","author":"KG Shojania","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9836","key":"ref87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"K Barnett","year":"2012","journal-title":"Lancet"},{"issue":"9286","key":"ref88","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(01)06111-6","article-title":"Approach to symptomatic coronary disease in the elderly: TIME to change?","volume":"358","author":"WS Aronow","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"ref89","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1756-0500-7-340","article-title":"Medical characteristics of the oldest old: retrospective chart review of patients aged 85+ in an academic primary care centre","volume":"7","author":"CS Tsoi","year":"2014","journal-title":"BMC Res Notes"},{"issue":"1","key":"ref90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2190\/AG.77.1.c","article-title":"The old, old-old, and the oldest old: continuation or distinct categories? an examination of the relationship between age and changes in health, function, and wellbeing","volume":"77","author":"J Cohen-Mansfield","year":"2013","journal-title":"Int J Aging Hum Dev"},{"issue":"46","key":"ref91","first-page":"3238","article-title":"Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis","volume":"36","author":"F Andreotti","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"ref92","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.114.011777","article-title":"Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF)","volume":"131","author":"BA Steinberg","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"ref93","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"JD Douketis","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"ref94","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(16)30369-2","article-title":"International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"17","author":"D Farge","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref95","article-title":"Venous thromboembolic diseases: diagnosis, management and thrombophilia testing","year":"2012","journal-title":"NICE guideline"},{"issue":"1","key":"ref96","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12913-018-2954-8","article-title":"Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use","volume":"18","author":"W Hoffmann-E\u00dfer","year":"2018","journal-title":"BMC Health Serv Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:17:16Z","timestamp":1589015836000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211695"}},"subtitle":[],"editor":[{"given":"Christophe","family":"Leroyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":96,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211695","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]}}}